DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
47 hedge funds and large institutions have $3.2M invested in DMK Pharmaceuticals Corporation Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
7
Closed
6
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
-$120K
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$1.68M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$37.9K |
| 3 |
HF
3
HRT Financial
New York
|
$16K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$14.9K |
| 5 |
5
Morgan Stanley
New York
|
$13.2K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
JPMorgan Chase & Co
New York
| $0 | 392 | -10 | -2% |
|
|
WAS
52
Winch Advisory Services
Appleton,
Wisconsin
| $0 | 73 | – | – |
|
|
CFGS
53
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
FIA
54
FNY Investment Advisers
New York
| – | – | – | – |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 92 | +36 | +64% |
|